LCD L38822: MolDX: Minimal Residual Disease Testing for Cancer — CGS
Policy LCD-L38822 · Oncology
Prepare for new billing guidelines in oncology testing.
Code intelligence
C81.91 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C81.91.
Normal code riskView ICD-10 detail
Signal breakdown
1 shown · 1 total in platform
Risk: Normal
0
Critical
0%
0
High
0%
1
Routine
100%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Routine
Audit documentation
Building an audit file that includes C81.91?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription